...
首页> 外文期刊>Pharmaceutical patent analyst >What is holding up the Unified Patent Court?
【24h】

What is holding up the Unified Patent Court?

机译:统一专利法院的是什么?

获取原文
获取原文并翻译 | 示例
           

摘要

A form of unified patent protection has been available in Europe since the 1970s, but enforcement remains purely a national matter. After many years' negotiation, an agreement was signed in February 2013 to create a pan-European court (the UPC), potentially affecting global litigation strategies. A constitutional complaint brought in Germany in 2017 has delayed the project and potentially presents an existential challenge, but more likely the issue is how much further delay it will cause. It remains entirely possible the UPC will start in Q1 2019 (before Brexit). In addition, for patentees such as pharmaceutical companies requiring broad geographic protection, another part of the new system, the unitary patent, would also mean a dramatic reduction in patent maintenance costs.
机译:自20世纪70年代以来,欧洲在欧洲提供了一种统一的专利保护形式,但执法仍然是国家事物。 经过多年的谈判,2013年2月签署了一项协议,以创造一个泛欧法院(UPC),可能影响全球诉讼策略。 2017年德国提出的宪法投诉推迟了该项目,并潜在呈现存在的挑战,但更有可能的问题是它会导致多少延误。 它仍然完全可能,UPC将于2019年第1季度(Brexit之前)开始。 此外,对于需要广泛地理保护的药物公司等专利人士来说,新系统的另一部分统一专利也意味着专利维持成本的急剧降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号